Bringing immunoglobulin knowledge up to date: how should we treat today?
- 15 July 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 166 (1) , 16-25
Abstract
Summary: Immunoglobulin (Ig) therapy is constantly evolving. Advances in the basic and clinical science of immunoglobulins have provided new perspectives in using polyclonal IgG to treat patients with primary immunodeficiencies. Recent meta-analyses of patient data and outcomes, optimization of IgG administration and better understanding of the IgG receptor variability and clinical effect are new concepts which practising immunologists can use in tailoring their approach to treating patients with primary immunodeficiencies. This manuscript presents the proceedings of a satellite symposium, held in conjunction with the European Society for Immunodeficiencies (ESID) 2010 meeting, to inform attendees about new scientific concepts in IgG therapy, with the goal of empowering expert level evaluation of what optimal IgG therapy is today.Keywords
This publication has 47 references indexed in Scilit:
- Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary ImmunodeficiencyClinical Pharmacokinetics, 2011
- The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropeniaSupportive Care in Cancer, 2010
- Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary ImmunodeficiencyJournal of Clinical Immunology, 2010
- Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficienciesClinical Immunology, 2010
- Functional and clinical consequences of Fc receptor polymorphic and copy number variantsClinical and Experimental Immunology, 2009
- Clinical Immunology Review Series: An approach to the management of pulmonary disease in primary antibody deficiencyClinical and Experimental Immunology, 2008
- Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptakeJournal of Experimental Medicine, 2008
- The European internet-based patient and research database for primary immunodeficiencies: results 2004–06Clinical and Experimental Immunology, 2007
- Global variation in copy number in the human genomeNature, 2006
- Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humansNature, 2006